ÌìÃÀ´«Ã½

HRH Princess Haya  Bint Khaled Bin Bandar Al Saud, Ph.D.

HRH Princess Haya Bint Khaled Bin Bandar Al Saud, Ph.D.

Hevolution Foundation

Vice President of Research

Expertise: ScienceTechnologyGenomics

HRH Princess Dr. Al Saud’s distinguished career includes roles at the King Abdulaziz City for Science & Technology (KACST), both as Director of the Saudi National Center for Genomics Technology, and as Director of the Saudi National Pre-Marital Screening Program. She also served as a scientist at the King Faisal Specialized Hospital and Research Center, where she carried out a range of research projects focusing on population genetics.

HRH Princess Dr. Al Saud has served as a member of the National Biotech Strategy Advisory Committee at the Strategic Management Office, and as a member of the National Nutrition Committee at the Saudi Food & Drug Authority, as well as being a past and present member of a number of other notable national and international committees. These include serving as a member of the Project Oversight Executive team for the Saudi Genome Project 2.0 at KACST; the S20 Future of Health Taskforce at the G20 Summit; and a committee member for the Princess Noura Award for Women’s Excellence.

HRH Princess Dr. Al Saud holds a PhD in Genomics of Common Diseases from Imperial College London and a Master’s degree in Genetics and Toxicology from McGill University, as well as a Bachelor’s degree in Clinical Nutrition from King Saud University, Riyadh.


No Research/Citations

Innovations Advancing Healthspan at Hevolution 2025

Can we reverse aging? With groundbreaking research in cellular rejuvenation, longevity medicine, and senolytics, scientists are pushing the boundaries of what’s possible. In this insightful discussion from the Global Healthspan Summit 2025, experts share the latest discoveries and the challenges of translating them into real-world healthcare solutions.
17-Feb-2025 05:05:57 PM EST

No Quotes

Available for logged-in users onlyLogin HereorRegister
close
0.08125